Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-04 · accession 0001415889-24-028466 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-06 | 2024-12-04 | ACRS | Walker Neal | INTERIM CEO, Dir | M - OptEx | $1.52 | +118.8K | 1.50M | +9% | +$180.6K |
| D | 2024-12-06 | 2024-12-04 | ACRS | Walker Neal | INTERIM CEO, Dir | F - Tax | $3.76 | -68.3K | 1.43M | -5% | -$257.0K |
| D | 2024-12-06 | 2024-12-04 | ACRS | Walker Neal | INTERIM CEO, Dir | M - OptEx | $0.00 | -118.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-04 | M | A | 118,840 | $1.52 | 1,501,973 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-04 | F | D | 68,343 | $3.76 | 1,433,630 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-12-04 | M | D | 118,840 | $0.00 | 0 | D | $1.52 · — to 2024-12-07 | 118,840 Common Stock | (F2) Fully vested and exercisable. |